Evaluation of mobile health technology combining telemonitoring and teleintervention versus usual care in vulnerable-phase heart failure management (HERMeS): a multicentre, randomised controlled trial.
Saved in:
| Title: | Evaluation of mobile health technology combining telemonitoring and teleintervention versus usual care in vulnerable-phase heart failure management (HERMeS): a multicentre, randomised controlled trial. |
|---|---|
| Authors: | Yun S; Faculty of Medicine and Health Sciences, University of Barcelona, Barcelona, Spain; Bio-Heart Cardiovascular Diseases Research Group, Bellvitge Biomedical Research Institute, L'Hospitalet de Llobregat, Barcelona, Spain; Community Heart Failure Program, Cardiology and Internal Medicine Department, Bellvitge University Hospital, L'Hospitalet de Llobregat, Barcelona, Spain; Internal Medicine Department, Bellvitge University Hospital, L'Hospitalet de Llobregat, Barcelona, Spain; Biomedical Research Networking Center on Cardiovascular Diseases, Carlos III Health Institute, Madrid, Spain., Comín-Colet J; Bio-Heart Cardiovascular Diseases Research Group, Bellvitge Biomedical Research Institute, L'Hospitalet de Llobregat, Barcelona, Spain; Community Heart Failure Program, Cardiology and Internal Medicine Department, Bellvitge University Hospital, L'Hospitalet de Llobregat, Barcelona, Spain; Cardiology Department, Bellvitge University Hospital, L'Hospitalet de Llobregat, Barcelona, Spain; Biomedical Research Networking Center on Cardiovascular Diseases, Carlos III Health Institute, Madrid, Spain; Department of Clinical Sciences, School of Medicine, University of Barcelona, Barcelona, Spain. Electronic address: josepcomin@gmail.com., Calero-Molina E; Bio-Heart Cardiovascular Diseases Research Group, Bellvitge Biomedical Research Institute, L'Hospitalet de Llobregat, Barcelona, Spain; Community Heart Failure Program, Cardiology and Internal Medicine Department, Bellvitge University Hospital, L'Hospitalet de Llobregat, Barcelona, Spain; Cardiology Department, Bellvitge University Hospital, L'Hospitalet de Llobregat, Barcelona, Spain., Hidalgo E; Community Heart Failure Program, Cardiology and Internal Medicine Department, Bellvitge University Hospital, L'Hospitalet de Llobregat, Barcelona, Spain; Cardiology Department, Bellvitge University Hospital, L'Hospitalet de Llobregat, Barcelona, Spain., José-Bazán N; Bio-Heart Cardiovascular Diseases Research Group, Bellvitge Biomedical Research Institute, L'Hospitalet de Llobregat, Barcelona, Spain; Community Heart Failure Program, Cardiology and Internal Medicine Department, Bellvitge University Hospital, L'Hospitalet de Llobregat, Barcelona, Spain; Cardiology Department, Bellvitge University Hospital, L'Hospitalet de Llobregat, Barcelona, Spain., Cobo Marcos M; Biomedical Research Networking Center on Cardiovascular Diseases, Carlos III Health Institute, Madrid, Spain; Cardiology Department, Puerta de Hierro Majadahonda University Hospital, Puerta de Hierro-Segovia de Arana Health Research Institute, Madrid, Spain., Soria T; Cardiology Department, Puerta de Hierro Majadahonda University Hospital, Puerta de Hierro-Segovia de Arana Health Research Institute, Madrid, Spain., Llàcer P; Internal Medicine Department, Hospital Universitario Ramón y Cajal, IRYCIS, Madrid, Spain; Department of Medicine and Medical Specialties, Facultad de Medicina y Ciencias de la Salud, Universidad de Alcalá, Madrid, Spain., Fernández C; Internal Medicine Department, Hospital Universitario Ramón y Cajal, IRYCIS, Madrid, Spain., García-Pinilla JM; Biomedical Research Networking Center on Cardiovascular Diseases, Carlos III Health Institute, Madrid, Spain; Cardiology Department, Heart Failure and Familial Cardiomyopathy Unit, Virgen de la Victoria University Hospital, Instituto de Biomedicina de Málaga-IBIMA Plataforma BIONAND, Málaga, Spain; Department of Medicine and Dermatology, Universidad de Málaga, Málaga, Spain., Cruzado C; Biomedical Research Networking Center on Cardiovascular Diseases, Carlos III Health Institute, Madrid, Spain; Cardiology Department, Heart Failure and Familial Cardiomyopathy Unit, Virgen de la Victoria University Hospital, Instituto de Biomedicina de Málaga-IBIMA Plataforma BIONAND, Málaga, Spain., González-Franco Á; Internal Medicine Department, Central de Asturias University Hospital, Foundation for Health and Biomedicine Research and Innovation of Asturias, Oviedo, Spain., García-Marina EM; Internal Medicine Department, Central de Asturias University Hospital, Foundation for Health and Biomedicine Research and Innovation of Asturias, Oviedo, Spain., Morales-Rull JL; Internal Medicine Department, Heart Failure Unit, Arnau de Vilanova University Hospital, Lleida Biomedical Research Institute's Dr Pifarré Foundation, Lleida, Spain., Solé C; Internal Medicine Department, Heart Failure Unit, Arnau de Vilanova University Hospital, Lleida Biomedical Research Institute's Dr Pifarré Foundation, Lleida, Spain., García-Romero E; Bio-Heart Cardiovascular Diseases Research Group, Bellvitge Biomedical Research Institute, L'Hospitalet de Llobregat, Barcelona, Spain; Cardiology Department, Bellvitge University Hospital, L'Hospitalet de Llobregat, Barcelona, Spain; Biomedical Research Networking Center on Cardiovascular Diseases, Carlos III Health Institute, Madrid, Spain; Advanced Heart Failure and Heart Transplant Program, Cardiology Department, Bellvitge University Hospital, L'Hospitalet de Llobregat, Barcelona, Spain., Núñez J; Biomedical Research Networking Center on Cardiovascular Diseases, Carlos III Health Institute, Madrid, Spain; Cardiology Department, Clinic of València University Hospital, Biomedical Research Institute of València, València, Spain; School of Medicine, University of València, València, Spain., Civera J; Cardiology Department, Clinic of València University Hospital, Biomedical Research Institute of València, València, Spain., Fernández C; Primary Care Service Delta Llobregat, Foundation University Institute for Research in Primary Health Care Jordi Gol I Gurina, L'Hospitalet de Llobregat, Barcelona, Spain., Faraudo M; Cardiology Department and Heart Failure Unit, Hospital Moisès Broggi/Hospital General de Hospitalet, Spain., Moliner P; Bio-Heart Cardiovascular Diseases Research Group, Bellvitge Biomedical Research Institute, L'Hospitalet de Llobregat, Barcelona, Spain; Community Heart Failure Program, Cardiology and Internal Medicine Department, Bellvitge University Hospital, L'Hospitalet de Llobregat, Barcelona, Spain; Cardiology Department, Bellvitge University Hospital, L'Hospitalet de Llobregat, Barcelona, Spain; Biomedical Research Networking Center on Cardiovascular Diseases, Carlos III Health Institute, Madrid, Spain; Cardio-Oncology Unit, Bellvitge University Hospital and Catalan Institute of Oncology, L'Hospitalet de Llobregat, Barcelona, Spain., Formiga F; Internal Medicine Department, Bellvitge University Hospital, L'Hospitalet de Llobregat, Barcelona, Spain; Bellvitge Biomedical Research Institute, L'Hospitalet de Llobregat, Barcelona, Spain., de-Juan Bagudá J; Biomedical Research Networking Center on Cardiovascular Diseases, Carlos III Health Institute, Madrid, Spain; Cardiology Department, University Hospital 12 de Octubre, Instituto de Investigación Sanitaria Hospital 12 de Octubre, Madrid, Spain; Departamento de Medicina, Facultad de Medicina, Salud y Deporte, Universidad Europea de Madrid, Madrid, Spain., Zegri-Reiriz I; Cardiology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain., Verdú-Rotellar JM; Biomedical Research Networking Center on Cardiovascular Diseases, Carlos III Health Institute, Madrid, Spain; Primary Care Service Litoral, Institut Català de la Salut, Barcelona, Spain; Department of Medicine, Universitat Pompeu Fabra, Barcelona, Spain., Vela E; Catalan Health Service, Barcelona, Spain; Digitalization for the Sustainability of the Healthcare System (DS3), Bellvitge Biomedical Research Institute, L'Hospitalet de Llobregat, Barcelona, Spain., Monterde D; Catalan Health Service, Barcelona, Spain; Digitalization for the Sustainability of the Healthcare System (DS3), Bellvitge Biomedical Research Institute, L'Hospitalet de Llobregat, Barcelona, Spain., Piera-Jiménez J; Catalan Health Service, Barcelona, Spain; Digitalization for the Sustainability of the Healthcare System (DS3), Bellvitge Biomedical Research Institute, L'Hospitalet de Llobregat, Barcelona, Spain; Faculty of Informatics, Telecommunications and Multimedia, Universitat Oberta de Catalunya, Barcelona, Spain., Carot-Sans G; Catalan Health Service, Barcelona, Spain; Digitalization for the Sustainability of the Healthcare System (DS3), Bellvitge Biomedical Research Institute, L'Hospitalet de Llobregat, Barcelona, Spain., Enjuanes C; Bio-Heart Cardiovascular Diseases Research Group, Bellvitge Biomedical Research Institute, L'Hospitalet de Llobregat, Barcelona, Spain; Community Heart Failure Program, Cardiology and Internal Medicine Department, Bellvitge University Hospital, L'Hospitalet de Llobregat, Barcelona, Spain; Cardiology Department, Bellvitge University Hospital, L'Hospitalet de Llobregat, Barcelona, Spain; Biomedical Research Networking Center on Cardiovascular Diseases, Carlos III Health Institute, Madrid, Spain. |
| Corporate Authors: | HERMeS trial investigators group |
| Source: | The Lancet. Digital health [Lancet Digit Health] 2025 May; Vol. 7 (5), pp. 100866. Date of Electronic Publication: 2025 May 14. |
| Publication Type: | Journal Article; Randomized Controlled Trial; Multicenter Study; Clinical Trial, Phase III; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Elsevier Ltd Country of Publication: England NLM ID: 101751302 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2589-7500 (Electronic) Linking ISSN: 25897500 NLM ISO Abbreviation: Lancet Digit Health Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
